Press release
Radionuclide Scanning Services Market Estimated to Flourish by 2017 – 2025
The radionuclide service providers includes the hospitals and private laboratories. Some of the key players in the radionuclide scanning services market include Sonic Healthcare, Aditya Birla Health Services Ltd., Cleveland Clinic, The London Clinic, The GEL Group, Inc., Alliance Medical, Global Diagnostics and many others.Radionuclide scanning also called nuclear medicine imaging is the test that scans internal body parts with the use of radioactive material. This overcomes the limitations of standard X-Ray systems to reach and scan every body part. A radionuclide is used as a label to the substance that accumulates in specific part of the body such as Iodine is used to make thyroid hormones and thus accumulates in the thyroid glands similarly, Diphosphonate accumulates where bone is repairing or rebuilding itself. The tracer is swallowed, inhaled or injected under the skin which emits gamma rays, so the doctors can detect the location of tracer by the use of special scanners or cameras. Highly qualified personnel are required for this process.
Radionuclide scanning can be used to visualize images in 2D using Scintigraphy technique as well as in 3D representation using SPECT. Some of the commonly used radionuclides for the service include Iodine-131, Yttrium-90, Samarium-153, Fluorine-18 and many others.
Radionuclide Scanning Services Market: Drivers & Restraints
With the surge in the nuclear medicine imaging industry, the radionuclide scanning services market is also anticipated to increase during the forecast period. Furthermore, wide applications of the technique, painless diagnosis and in-depth analysis results in increasing the market. In most of the developing and under-developed countries, less popularity of the technique and high cost is the restraining factor for the market to grow in. The harmful effects of the radiations also hinders the growth in the diagnosis services market. Lack of skilled personnel for carrying out the diagnostic practices using radionuclide tracers is also a limiting factor in the market growth.
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/16639
Radionuclide Scanning Services Market: Segmentation
By Visualization Type:
Heart blood flow and functions
Differential lung function
Body Infections & inflammations
Bone fracture & infections
Gall Bladder & Bile Duct Functions
Gastrointestinal bleeding
Tumor Localization
Others
By Applications
Diagnosis
Prognosis
By Distribution Channels
Hospitals
Clinics
Diagnostic Centers
By Geography
North America
Europe
Latin America
Asia-Pacific
Middle East and Africa
Large number of players in the market increases the competition. R&D activities, continuous innovation and improvisation of the technique also helps in moving the market ahead. Providing safe, cost effective and reliable services is the demand in the market. The brand name of various service providers are attracting the business. Various marketing strategies are adopted by the service providers to lure the doctors and patients for the services.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/16639
A geographic condition regarding the radionuclide scanning services market, it has been segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. North America holds the largest market share in the radionuclide scanning services due to large number of service providers in the region, good reimbursement scenario and health facilities in the reach of most of the population. This is followed by Europe because of better healthcare infrastructure and large number of government funded hospitals and laboratories. Asia-Pacific is still considered to be the growing segment because of increasing number of service providers in the region, but does not meet the high population density in the region.
To view complete report @ http://www.persistencemarketresearch.com/market-research/radionuclide-scanning-services-market.asp
About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radionuclide Scanning Services Market Estimated to Flourish by 2017 – 2025 here
News-ID: 623559 • Views: …
More Releases from Persistence Market Research
High Power Industrial Burner Market Projected to Reach US$ 2,304.4 Million by 20 …
The global high power industrial burner market is experiencing steady growth, with the market size expected to increase from US$ 1.727 billion in 2025 to US$ 2.304 billion by 2032, reflecting a CAGR of 4.2% during the forecast period. High power industrial burners are critical components in industrial heating systems, providing controlled combustion for furnaces, boilers, kilns, and other thermal processes. Their role in enhancing energy efficiency, reducing emissions, and…
Welded Metal Bellows Market Expected to Reach US$ 516.8 Million by 2033 | Persis …
The global welded metal bellows market is projected to experience substantial growth in the coming years, with its valuation expected to rise from US$ 346.0 million in 2026 to US$ 516.8 million by 2033, reflecting a CAGR of 5.9% during the forecast period. Welded metal bellows, which are flexible, airtight, and highly durable components, are widely used in applications requiring vibration absorption, thermal expansion compensation, and precise vacuum sealing. Their…
Ship-to-Shore Container Cranes Market Poised to Reach US$ 4.9 Billion by 2033 | …
The global ship-to-shore (STS) container cranes market is poised for substantial growth, with the market expected to reach a valuation of US$ 4.9 billion by 2033, up from US$ 3.6 billion in 2026. This growth reflects a CAGR of 4.4% over the forecast period, highlighting the increasing adoption of advanced port handling solutions worldwide. Ship-to-shore container cranes are critical infrastructure in modern maritime logistics, designed to efficiently load and unload…
Nickel-Metal Hydride Battery Market Predicted to See Expansion to US$ 4.9 Billio …
According to the latest study by Persistence Market Research, the global Nickel-Metal Hydride Battery Market is expected to be valued at US$ 3.6 billion in 2026 and is projected to reach US$ 4.9 billion by 2033, growing at a CAGR of 4.5% between 2026 and 2033. Despite the rapid rise of lithium-ion technologies, NiMH batteries continue to maintain strong relevance due to their safety profile, long cycle life, and established…
More Releases for Radionuclide
Radionuclide Drug Conjugates (RDCs) Market Growth Set to Surge Significantly by …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook And Industry Analysis 2031"
The Global Radionuclide Drug Conjugates (RDCs) Market is expected to grow with a CAGR…
Radionuclide Therapy Equipment Market Size And Global Industry Forecast 2034
" In 2024, the global radionuclide therapy equipment market is valued at approximately $4.3 billion, driven by increasing prevalence of cancer and advancements in targeted therapies. The market is projected to reach around $7.8 billion by 2034, reflecting significant growth opportunities primarily attributed to technological advancements, enhanced diagnostic capabilities, and a rising focus on personalized medicine. "
Exactitude Consultancy., Ltd. released a research report titled "Radionuclide Therapy Equipment Market". This report…
Antibody-radionuclide Conjugates Market Share Research Report 2025
On Mar 6, 2025, Global Info Research released a research report titled "Global Antibody-radionuclide Conjugates Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides detailed data analysis of the Antibody-radionuclide Conjugates market from 2020 to 2031. Including the market size and development trends of Antibody-radionuclide Conjugates Market, it analyzes market size indicators such as sales, sales volume, average price and CAGR, it also provides a…
Radionuclide Drug Conjugates (RDCs) Market Robust Expansion is expected to 2031
Radionuclide Drug Conjugates (RDCs) Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook…
Radionuclide Drug Conjugates (RDC) Market Minimizing Side Effects, Maximizing Im …
Radionuclide Drug Conjugates (RDCs) Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook…
Peptide Receptor Radionuclide Therapy Market Analysis, Size, Current Scenario an …
Peptide Receptor Radionuclide Therapy Market is anticipated to grow at a significant CAGR during the forecast period. The increasing prevalence of neuroendocrine tumors is expected to impel the demand for peptide receptor radionuclide therapy (PRRT) as an increasing number of the patient pool. The establishment of reimbursement policies for Lutathera favors the demand for peptide receptor radionuclide therapy (PRRT).
Moreover, increasing clinical trials for the new radiopharmaceuticals drugs approval for cancer…
